Guangdong VTR Bio-Tech Co., Ltd.

Shenzhen Stock Exchange 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd. Operating Cash Flow for the year ending December 31, 2023: USD 21.75 M

Guangdong VTR Bio-Tech Co., Ltd. Operating Cash Flow is USD 21.75 M for the year ending December 31, 2023, a -39.92% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Guangdong VTR Bio-Tech Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 36.19 M, a 6.02% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 34.14 M, a -44.80% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 61.85 M, a -2.59% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Operating Cash Flow for the year ending December 31, 2019 was USD 63.49 M, a 114.12% change year over year.
Key data
Date Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid
Market news
SV Wall Street
Shenzhen Stock Exchange: 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd.

CEO Mr. Derong Zhou
IPO Date Jan. 28, 2014
Location China
Headquarters No. 8 Pingbei Road 1
Employees 1,119
Sector Healthcare
Industries
Biotechnology Agriculture Biofuel Fertilizers Personal Care Pet Food Pharmaceuticals Plastics
Description

Guangdong VTR Bio-Tech Co., Ltd., focuses on research, development, and industrial application of bio-medicine, bio-agriculture, and animal husbandry. The company provides feed enzymes, functional feed additives, and industrial enzyme products. The company sells its products in approximately 60 countries and regions. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is headquartered in Zhuhai, China.

StockViz Staff

February 3, 2025

Any question? Send us an email